hormone-therapy

Documents about hormone-therapy

• Can we Use Estrogen-containing Therapy to Improve Pain in Women After Menopause With Hand Osteoarthritis?#810214ClinicalTrials.gov
• Letrozole Versus Hormonal Preparation in Frozen Cycles of PCOS Patients.#826105ClinicalTrials.gov
• Factors Associated With the Acne Severity Among Transmen Population: a Cross-sectional Study#835191ClinicalTrials.gov
• Radiotherapy Plus Hormone Therapy in Biochemically-relapsing Prostate Cancer Patients Following Surgery#911259ClinicalTrials.gov
• A Feasibility Trial of a Web Based App Intervention in Hormone Positive Breast Cancer Patients to Improve Adherence to Endocrine Therapy#839277ClinicalTrials.gov
• Thyroid hormone changes after tumor necrosis factor inhibitor therapy in euthyroid patients with rheumatic diseases#255613Recep Tayyip Erdoğan University Institutional Repository
• Combination of Chidamide and Fulvestrant for HR+/HER2- Breast Cancer That Has Failed Previous CDK4/6 i Adjuvant Therapy#840192ClinicalTrials.gov
• Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors#870179ClinicalTrials.gov
• Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate Cancer#969429ClinicalTrials.gov
• Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer#892124ClinicalTrials.gov
• Menopausal hormone therapy at age 45 to 60 years old, future dementia or cognitive decline: Systematic review and meta-analysis#214814bioRxiv / medRxiv
• Hormone Therapy Use and Risk of Chronic Disease in the Nurses’ Health Study: A Comparative Analysis With the Women's Health Initiative#384117CiNii
• Traumatic brain injury associated with altered corpus callosum microstructure in females: Exploring the roles of menopause timing and hormone therapy in UK biobank.#645194NCBI PubMed Central
• Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer#912104ClinicalTrials.gov
• A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer#867522ClinicalTrials.gov
• An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)#848895ClinicalTrials.gov
• Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer#884503ClinicalTrials.gov
• Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy#845609ClinicalTrials.gov
• The MUSE Study for Menopausal Arthralgia#872649ClinicalTrials.gov
• Expression of Endometrium During Window of Implantation#874016ClinicalTrials.gov
• What is the Optimal Cycle Regimen for Frozen- Thawed Embryo Transfer Cycles#880710ClinicalTrials.gov
• SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer#891357ClinicalTrials.gov
• Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer#969973ClinicalTrials.gov
• The EMPOwER Study Evaluating Multiparameter Gene Testing as a Predictor of Short Term Endocrine Therapy Response in Hormone Receptor Positive Breast Cancers#1010681ClinicalTrials.gov
• Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial#802756ClinicalTrials.gov
• A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer#1008650ClinicalTrials.gov
• PSMA PET-Guided Progression-Directed Radiotherapy for Oligoprogressive Prostate Cancer#913239ClinicalTrials.gov
• Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer#825595ClinicalTrials.gov
• Unscheduled bleeding and endometrial cancer in women on postmenopausal hormone replacement therapy and their matched controls: protocol for a descriptive cohort study using the Orchid-e database#192365bioRxiv / medRxiv
• Hormonal and anthropometric factors associated with depression in postmenopausal women : results from the E3N cohort#235055HAL Science
• Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 study#665182HAL (France)
• Progestin (Progesterone-Like Hormones) Induced Dysphoria (Depressed Mood, Irritability, Anxiety)#848317ClinicalTrials.gov
• SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy#875398ClinicalTrials.gov
• Immunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer, the REINA Trial#460103ClinicalTrials.gov
• Supplementary Material for: GnRH Analog followed by Sex Hormone Therapy as a Preventive Strategy against Ovarian Complications in Congenital Lipoid Adrenal Hyperplasia: A Case Report#279898Figshare
• Geriatric Oncology Assessment and Coping Skills Training for Older Women on Aromatase Inhibitor Therapy#801145ClinicalTrials.gov
• Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System#811173ClinicalTrials.gov
• Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy#846432ClinicalTrials.gov
• Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan#913994ClinicalTrials.gov
• AMH Dynamic Changes to Predict Ovarian Reserve in Perimenopausal Breast Cancer#813836ClinicalTrials.gov
• Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy#828366ClinicalTrials.gov
• Evaluation of the Effects of Using Cooling Pillowcases, on the Symptoms of Hot Flushes, Sleep and Life Quality#848131ClinicalTrials.gov
• Efficacy and Safety of Estradiol and Progesterone Microspheres for the Treatment of Climacteric Symptoms.#868344ClinicalTrials.gov
• Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer#894711ClinicalTrials.gov
• Women's Experience of Premature Ovarian Insufficiency (POI) Diagnosis: Update on Actual Practices and Patient's Follow up#912787ClinicalTrials.gov
• Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy#911308ClinicalTrials.gov
• Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)#883953ClinicalTrials.gov
• Fulvestrant versus capecitabine as maintenance therapy in hormone receptor-positive, HER2-negative metastatic breast cancer after first-line chemotherapy (FAMILY): a multicenter, open-label, randomized, phase 3 trial.#221242NCBI PubMed Central
• Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy#845072ClinicalTrials.gov
• Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy#911290ClinicalTrials.gov